// App-Quantinova.ai

6086 : Phase II study on lenvatinib (LEN) in recurrent and/or metastatic (R/M) adenoid cystic carcinomas (ACC) of the salivary glands (SG) of the upper aereodigestive tract (NCT02860936).

Researchers

Presenter

  • Laura Locati

Principal Investigators

  • Donata Galbiati

  • Giuseppina Calareso

  • Salvatore Alfieri

  • Roberta Granata

  • Paolo Bossi

  • Cristiana Bergamini

  • Carlo Resteghini

  • Stefano Cavalieri

  • Francesca Platini

  • Pasquale Quattrone

  • Moela Mancinelli

  • Andrea Zucchella

  • Luigi Mariani

  • Guido Fedele

  • Lisa F. Licitra

Medical Centers

  • Division of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Division of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Division of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Division of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Division of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • High Research S.R.L., Milan, Italy

  • Head and Neck Cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori - University of Milan, Milan, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Acetyl-CoA carboxylase

  • Circulating tumor cells

Drug/Treatment

  • Lenvatinib

Outcome

  • Indeterminate

Study Design

  • N/A

Phase

  • II

Study Id's

  • NCT02860936

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved